Compounded GLP-1 to Brand-Name: Your Transition Guide
The FDA is ending the compounded GLP-1 era. Here's your complete guide to transitioning to FDA-approved alternatives — Foundayo, Ozempic, Wegovy, Zepbound, or Mounjaro.
Why You Must Switch Now
The compounded GLP-1 market is facing an existential crisis. See our full breakdown of compounded semaglutide alternatives:
- FDA has removed semaglutide from the shortage list — compounding pharmacies lose their legal exemption
- Lilly is aggressively litigating against tirzepatide compounders
- Quality is inconsistent — FDA has documented wide dose variability in compounded products
- Your supply could end any day — pharmacies are shutting down with little notice
Don't wait for a forced transition. Plan your switch now. For semaglutide users, see our compounded semaglutide to Foundayo guide. For tirzepatide users, see compounded tirzepatide to Foundayo.
Oral GLP-1 tablets now available — from $99/mo
Done with injections? MEDVi offers GLP-1 pills and tablets alongside injectables. Take a 60-second quiz to see your options.
See Oral GLP-1 Options →Compare Your Brand-Name Options
| Option | Form | List Price | Best For |
|---|---|---|---|
| Foundayo | Daily pill | $149-349/mo | Lowest cost, oral convenience |
| Ozempic | Weekly injection | $936/mo | Staying on semaglutide |
| Wegovy | Weekly injection or pill | $1,349/mo | Max semaglutide weight loss |
| Zepbound | Weekly injection | $499/mo (LillyDirect) | Max weight loss (tirzepatide) |
For most patients on compounded GLP-1s, Foundayo is the best transition: affordable, oral, no food restrictions, and FDA-approved. Compare options: Foundayo vs compounded semaglutide, Foundayo vs Ozempic, Foundayo vs Wegovy, Foundayo vs Zepbound.
Oral GLP-1 tablets now available — from $99/mo
Done with injections? MEDVi offers GLP-1 pills and tablets alongside injectables. Take a 60-second quiz to see your options.
See Oral GLP-1 Options →Done with injections? Oral GLP-1 pills available.
MEDVi offers GLP-1 tablets from $99/mo — no injection required.
Insurance & Savings Cards
Brand-name GLP-1s have manufacturer savings programs that can dramatically reduce cost:
- Lilly (Foundayo, Zepbound): Savings card at LillyDirect.com — as low as $25/month for insured patients
- Novo Nordisk (Ozempic, Wegovy): Savings card — as low as $25/month for commercially insured patients
- Without insurance: Foundayo at $149-349/month is the most affordable option at list price. See our best GLP-1 without insurance guide
Step-by-Step: How to Make the Switch
Compare GLP-1 Providers — Oral & Injectable
These vetted providers offer both GLP-1 pills/tablets and injections. A licensed provider helps you choose the right format.
GLP-1 weight loss program — take a 60-second quiz to see if you qualify. Compounded semaglutide and tirzepatide from $99/month with provider support.
Starts at $99/mo — one of the most affordable GLP-1 programs
MedSwitcher may earn a commission from some providers. Full disclosure. This does not affect our recommendations.
Calculate Your Personalized Switch Plan
Enter your current medication and dose to get a detailed switching plan with dose mapping, timeline, and cost analysis.
Have your plan? Oral GLP-1 options start at $99/mo.
MEDVi offers GLP-1 tablets and pills — a provider helps you choose.
Frequently Asked Questions
Sources & Citations
- FDA statements on GLP-1 compounding enforcement
- FDA testing of compounded semaglutide quality (2024-2025)
- Manufacturer savings card programs (Lilly, Novo Nordisk)
Don't miss price changes
GLP-1 prices are changing — stay ahead
Foundayo prices may increase — get alerts before they do. Track price drops, shortages, and new switching guidance without checking back manually.
- Price increase warnings before they hit
- Savings card and coupon alerts
- New switching guidance and availability updates
No spam. Unsubscribe anytime. We never share your email.
Recommended Products
Supplies and tools commonly used by GLP-1 patients during their treatment journey.
As an Amazon Associate, MedSwitcher earns from qualifying purchases. Product links do not affect our clinical recommendations.